The time for labeling buildings where unborn children are put to death as abortion “clinics” can now be declared officially over. With a stroke of his pen, a single federal judge in Maryland has struck down a longstanding health regulation from the Food and Drug Administration that was designed to provide women with a modicum of contact with a member of the medical profession.
SBA List Responds to Federal Judge Blocking FDA Regulations to Require Doctor Visits to Obtain Dangerous Abortion Drugs
“We are extremely disappointed to see the courts once again side with the big abortion industry against women. Abortion activists exploiting the COVID-19 pandemic to push their long-sought goal of expanding dangerous chemical abortion drugs have proven over and over that they will prioritize profits at the expense of health and safety,” said SBA List President Marjorie Dannenfelser.
Pro-life Leaders Urge FDA: Protect Women, Enforce Regulations on Dangerous Abortion Drugs
“We urge the FDA to protect American women from dangerous abortion drugs entering the U.S. market illegally from overseas. AidAccess, Rablon, and the abortion radicals who operate these illegal pill-mills jeopardize women’s health and safety every day they continue to operate,” said SBA List President Marjorie Dannenfelser.
Dannenfelser and Listing: Gov. Whitmer’s Abortion Extremism Betrays Michiganders
SBA List President Marjorie Dannenfelser and Barbara Listing, President of Right to Life of Michigan on Michigan Governor Whitmer’s unabated abortion extremism during the coronavirus crisis: Governor Gretchen Whitmer’s mishandling of the COVID-19 crisis has been marked by one abuse of government power after another. Perhaps her most upsetting move was when she called abortion […]
Hydroxychloroquine Use During Pregnancy
In recent weeks, hydroxychloroquine (HCQ) has received significant media attention because of initial reports that suggest that it could be an effective treatment for the highly infectious respiratory disease, COVID-19, caused by the novel coronavirus, SARS-CoV-2. As of April 20, 2020, the results of these small studies await corroboration and confirmation from larger, more comprehensive […]